Outlook on the Global Prefilled Syringes Market (2020 to 2030) - Prefilled Syringes in Autoinjectors and Pen Injectors Presents Opportunities

DUBLIN, Feb. 21, 2020 /PRNewswire/ -- The "Prefilled Syringes Market (5th Edition), 2020-2030" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the current market landscape of prefilled syringes and the likely future opportunities associated with such devices, over the next 10-12 years. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

One of the key objectives of the report was to evaluate the current market size and the future opportunity within the prefilled syringes market. Based on various relevant parameters, such as the number of commercialized combination products, annual adoption rate, and expected pricing, the report provides an informed estimate of the likely evolution of the market over the period 2019-2030.

In order to provide a detailed future outlook, projections have been segmented on the basis of:

Therapeutic area (autoimmune disorders, infectious diseases, neurological disorders, blood disorders, oncological disorders, psychiatric disorders, respiratory disorders, cardiovascular disorders, metabolic disorders, ophthalmic diseases, orthopedic disorders and others)
Type of syringe
Type of material (glass and plastic)
Number of chambers (single chamber and dual chamber)
Type of drug molecule (antibodies, proteins, vaccines, small molecules, peptides, and others), and
Key geographies (North America, Europe (the UK, France, Italy, Spain, Germany and the rest of Europe), Latin America (Brazil, Mexico, Argentina and the rest of Latin America), Asia Pacific (Japan, China, India, South Korea and the rest of Asia Pacific), and the Middle East and Africa (Saudi Arabia, UAE, Africa and the rest of the Middle East))

In addition to other elements, the study includes:

An overview of the current market landscape of companies engaged in manufacturing prefilled syringes, providing information on year of establishment, company size, geographical location of the headquarters and manufacturing facilities, type of material used (glass and plastic), number of barrel chambers (single chamber and dual chamber), type of needle system (fixed needle system, luer lock and luer cone) and syringe volume.
An overview of the current market landscape of companies that are developing drugs in combination with prefilled syringes, featuring information on year of establishment, company size, geographical location of the developers, target therapeutic area, phases of development, type of drug molecule, route of administration, approval year (for marketed products), dosage details (for marketed products) and other approved dosage forms (for marketed products).
A detailed competitiveness analysis of the various prefilled syringes that we came across, taking into consideration the supplier power (based on the employee size of developer/manufacturer and their respective annual revenues) and key product specifications, such as number of chambers in the barrel, number of needle systems, volume of the barrel, technological advancement/user-friendliness and other distinguishing features.
A list of marketed drugs/therapies and pipeline candidates that are likely to be developed in combination with prefilled syringes in the near future, shortlisted based on an in-depth analysis that takes into consideration various relevant parameters, such as route of administration, type of drug molecule, target indications, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs).
An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe manufacturers (with regard to likely collaboration opportunities for combination product development) based on different parameters, such as pipeline strength, target therapeutic indication(s) and developer strength.
An analysis of the various prefilled syringe combination product-related initiatives of big pharma players, based on parameters, such as current adoption (based on number of approved and under development prefilled syringe combination products) and likely future adoption (based on potential injectable product candidates in the pipeline that are likely to be delivered via prefilled syringes), target therapeutic area(s) and type of drug molecule.
A review of the landscape of contract fill/finish services providers that offer services for prefilled syringes, featuring a list of active (large-sized) service providers and analysis based on a number of relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), type of drug molecule (biologics and small molecules), and geographical location of the service provider.
A detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies involved in developing and manufacturing such solutions.
An informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries/geographical regions.
Brief discussions of currently available specialty syringes, which include prefilled flush syringes, prefilled diluent syringe systems and prefilled contrast agent delivery systems.
A case study on companies that are engaged in the manufacturing of autoinjectors, featuring brief profiles of key players in this domain; each profile includes an overview of the firm, and information on its respective product portfolio.
Elaborate profiles of prominent prefilled syringe manufacturers engaged in this domain, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.
Elaborate profiles of prominent prefilled syringe component manufacturers, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.

Growth Drivers

Rising Incidence of Chronic Diseases
Growing Preference for Self-Injection
Evolving Patient Demographics
Growth of Biologics and Biosimilars Market
Changing Pharmaceutical Strategies
Increasing Focus on Prevention of Needlestick Injuries
Prefilled Syringes in Autoinjectors and Pen Injectors

Companies Mentioned

3D Medicines
Abbott
AbbVie
Abivax
Ablynx
Acceleron Pharma
Accord Healthcare
Activa Brand Products
Adamis Pharmaceuticals
Adimmune
Adocia
Advance Pharma Lab
Aerpio Therapeutics
Affibody
Agenus
Aguettant
Aijex Pharma International
Ajinomoto Bio-Pharma Services
Akeso Biopharma
AKRA DERMOJET
Akums Drugs & Pharmaceuticals
Al Biosciences
Alder BioPharmaceuticals
Alexion
Alfa Corpuscles
Alfasigma
Alkermes
Allergan
Alnylam Pharmaceuticals
Alphamab Jilin
Altor BioScience
Alvogen
Alvotech
Alzheimer's Association
AMAG Pharmaceuticals
Amega Biotech
Amgen
AMRI
AnaptysBio
Andes Biotechnologies
Antares Pharma
Antev
Apellis Pharmaceuticals
APL (Apotek Produktion & Laboratorier)
Apobiologix
Aptar Pharma
Aquabiliti
Araclon Biotech
Archivel Farma
Arecor
Arrowhead Pharmaceuticals
Arte
Asarina Pharma
Ascendis Pharma
ASIT biotech
Assistance Publique Hpitaux de Paris
Astellas Pharma
AstraZeneca
AV7
Axon Neuroscience
B. Braun Medical
Bavarian Nordic
Baxalta
Baxter
Bayer
Becton Dickinson
Bespak
Beximco Pharma
Biocad
Biocon
Biocorp
Biogen
BioGenCell
Bioinova
BioLineRx
BioMarin Pharmaceutical
BioMimetix
BioPharma Solutions (a business unit of Baxter)
BioValve Technologies
BirgiMefar
Boehringer Ingelheim
Bone Therapeutics
Boryung Pharmaceutical
Boston Biomedical
Boston Pharmaceuticals
Bracco Diagnostics
Braeburn Pharmaceuticals
Bristol-Myers Squibb
Brooklyn ImmunoTherapeutics
Caladrius Biosciences
Camurus
CARBOGEN AMCIS
Cardinal Health
Catalent
Catalyst Biosciences
CeleCor Therapeutics
Celgene
Celldex Therapeutics
Celltrion
Cenexi
Centrexion Therapeutics
CinnaGen
Ciron Drugs
Civi Biopharma
Coherus Biosciences
Consort Medical
Corden Pharma
Corvidia Therapeutics
Covidien
Credence Medsystems
CrossJect
CSL Behring
CSPC ZhongQi Pharmaceutical Technology
CytoDyn
Daewoong Pharmaceutical
Daiichi Sankyo
DALI Medical Devices
Datwlyer
Delpharm
DiaMedica Therapeutics
Dicerna Pharmaceuticals
Dr. Reddy's Laboratory
Dynavax Technologies
E3D
Eisai
Elcam Medical
Eli Lilly
Eloxx Pharmaceuticals
Emcure Pharmaceuticals
EMD Serono
Emergent BioSolutions
Enzon Pharma
Ever Pharma
Excelsior Medical
Ferring Pharmaceuticals
Follicum
Foresee Pharmaceutical
Fresenius Kabi
Fujifilm Kyowa Kirin Biologics
Future Injection Technologies
Galapagos
GC Pharma
GE Healthcare
Genentech
Generon (Shanghai)
Genexine
Genocea Biosciences
Genzyme
GERCOR
Gerresheimer
Getz Pharma
Gland Pharma
GSK
Guerbet
HAL Allergy
Hanmi Pharmaceutical
Harbour BioMed
Haselmeier
Healthcare Pharmaceuticals
Helixmith
Hengrui Yuanzheng Bio-Technology
Heron Therapeutics
Hetero Drugs
Hexal
IDT Biologika
Iltoo Pharma
Il-Yang Pharmaceutical
Immune Response BioPharma
ImmunoVaccine
Immunovant Sciences
Immutep Australia
Injecto
Injex
Inmune Bio
Innovent Biologics
Inovio Pharmaceuticals
Intas Pharmaceuticals
Intron Biotechnology
Ionis Pharmaceuticals
Ipsen
ISU Abxis
Italfarmaco
Izana Bioscience
J.O. Pharma
Janssen
Jiangsu Hansoh Pharmaceutical
Jiangsu HengRui Medicine
Jiangsu Hualan Pharmaceutical New Material
Jiangsu T-Mab Biopharma
Jiangxi Sanxin Medtec
Jinan Youlyy Industrial
Johnson & Johnson
Kaleo Pharma
Kang Stem Biotech
Kemwell Biopharma
KeyBioscience
Kezar Life Sciences
Kiniksa Pharmaceuticals
Kyowa Hakko Kirin
La Jolla Pharmaceutical
Laboratorios SALVAT
LEO Pharma
LG Chem
LIB Therapeutics
Lonstroff
Lonza
Lundbeck
Luye Pharma
M3 Biotechnology
Mada Medical Products
Mallinckrodt
Medefil
Medicago
MedicalChain International
Medigen Vaccine Biologics
MedImmune
MedPro Safety Products
Medtronic
MedxL
Merck
Merck Serono
Meridian
Merit Medical
Mika Medical
Millendo Therapeutics
Millennium Pharmaceuticals
Minervax
miRagen Therapeutics
Mithra Pharmaceuticals
Mitsubishi Tanabe
Modus Therapeutics
Mologen
Mylan
Nektar Therapeutics
Nemera
NeoImmuneTech
Neumedicines
Neuraly
NGM Biopharmaceuticals
Ningbo Zhengli Pharmaceutical Packing
NIPRO
Nora Therapeutics
Nordic Bioscience
NovaDigm Therapeutics
Novartis
Novavax
Novo Nordisk
NPS Pharmaceuticals (a subsidiary of Shire)
Nuance Designs
Nurse Assist
OBI Pharma
OliPass
Olix Pharmaceuticals
Ology Bioservices
Omeros
Ompi
Oncobiologics
Oncolix
OncoPep
OncoTherapy Science
Oncovir
OPKO Health
Optimum Medical
Orphan Disease Treatment Institute
Osivax
Otsuka Pharmaceutical
Oval Medical Technologies
Owen Mumford
PA Consulting
Palatin Technologies
Patheon
PCI Pharma Services
PegBio
PenJet
Pfizer
Pfizer CentreOne
PharmaJet
PhaseBio Pharmaceuticals
PHC Injection Device Technologies
Piramal Enterprises
Pisa Farmaceutica
Plas-Tech Engineering
Pluristem Therapeutics
Polaris Group
PRA Health Sciences
Primequal
ProJect Pharmaceutics
Promius Pharma
Protagonist Therapeutics
Proteo Biotech
Qilu Pharmaceutical
Qu Biologics
Quratis
Ra Pharmaceuticals
Rafa Laboratories
Raumedic
Regenera Pharma
Regeneron
Reliance Life Sciences
REMD Biotherapeutics
Rentschler Biopharma
Retractable Technologies
Revolutions Medical
RHEACELL
Rhythm Pharmaceuticals
Roche
Roselabs biosciences
Rovi Pharmaceutical
R-Pharm
Samsung Bioepis
Samsung Biologics
Sandoz
Sanofi
SCHERDEL Medtec
Schering Medipharm
Schott
Schott-Kaisha
Seqirus
Serina Therapeutics
Shandong Pharmaceutical Glass
Shandong Weigao
Shandong Zibo Minkang Pharmaceutical Packing
Shanghai Biomabs Pharmaceutical
Shenyang Sunshine Pharmaceutical
Shin Yan Sheno Precision Industrial
Shire
SHL Group
Siegfried Holding
Sinocelltech
SiO2 Medical Products
Smiths Medical
Swedish Orphan Biovitrum (SOBI)
Spectrum Pharmaceuticals
Splash Pharmaceuticals
Square Pharmaceuticals
SRI International
Stealth BioTherapeutics
Sun BioPharma
Sun Pharma
Suzuken
SynDevRx
Synermore Biologics
Taisei Kako
Takeda
Terumo Europe
Teva Pharmaceutical
The Medical House
The Medicines Company
The National Medical Products
Themis Bioscience
Therachon
TikoMed
Tip-Top
Tolmar
Transcoject
Transgene
Troikaa
Turnstone Biologics
Tyfill Pharmapack
UCB Biopharma
Union Medico
United Neuroscience
US Medical Instruments
Vaccibody
Vaccitech
Valeant Pharmaceutical
Valeritas
Valneva
Vaxine
Vetter Pharma
Viela Bio
ViiV Healthcare
Vir Biotechnology
Viriom
Vitaeris
VLP Therapeutics
West Pharmaceutical
Xbiotech
XEME Biopharma
YangZhong Wealth Metal
YL Biologics
Ypsomed
Zealand Pharma
Zhejiang Huahai Pharmaceutical
Zogenix
ZymoGenetics

For more information about this report visit https://www.researchandmarkets.com/r/46ep1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Market News and Data brought to you by Benzinga APIs